bovin
respiratori
diseas
complex
common
diseas
requir
use
antimicrobi
industri
calf
product
worldwid
pathogen
bacteria
mannheimia
haemolytica
mh
pasteurella
multocida
pm
histophilu
somni
hs
mycoplasma
bovi
rang
virus
bovin
respiratori
syncyti
viru
bovin
coronaviru
bovin
parainfluenza
viru
type
bovin
viral
diarrhea
viru
bovin
herpesviru
type
associ
complex
pathogen
present
healthi
diseas
calv
simpl
detect
presenc
diseas
calv
carri
low
predict
valu
multiag
diseas
livestock
quantif
pathogen
ad
substanti
predict
valu
microbiolog
diagnosi
aim
studi
evalu
abil
two
recent
develop
quantit
pcr
qpcr
kit
detect
quantifi
bacteri
viral
pathogen
respect
test
effici
qpcr
assay
base
nucleic
acid
dilut
seri
target
bacteria
virus
respect
assay
detect
limit
copi
nucleic
acid
strain
target
bacteria
correctli
identifi
fals
posit
reaction
strain
nontarget
bacteri
speci
base
standard
curv
log
cfu
versu
cycl
threshold
ct
valu
quantif
possibl
rang
bacteria
tracheal
aspir
sampl
kappa
valu
agreement
bacteri
cultur
mh
pm
hs
addit
tracheal
aspir
agreement
pneumo
certifi
diagnost
qpcr
assay
moder
bovi
high
viral
pathogen
thu
kit
specif
detect
quantifi
relev
pathogen
bovin
respiratori
diseas
brd
common
calv
two
week
six
month
age
major
caus
livestock
mortal
beef
calv
feedlot
johnson
et
al
larsen
et
al
virtala
et
al
wide
rang
pathogen
involv
brd
includ
bovin
respiratori
syncyti
viru
brsv
bovin
coronaviru
bcov
bovin
parainfluenza
viru
type
mannheimia
haemolytica
pasteurella
multocida
histophilu
somni
mycoplasma
bovi
angen
et
al
frii
krogh
kusiluka
et
al
larsen
et
al
tegtmeier
et
al
bovin
herpesviru
bovin
viral
diarrhoea
viru
bvdv
also
contribut
pathogen
erad
sever
countri
includ
denmark
unit
state
feedlot
affect
brd
arriv
brd
incid
medium
larg
australian
feedlot
report
hay
et
al
estim
mortal
rate
danish
dairi
calv
brd
consid
respons
death
et
al
recent
investig
calf
mortal
irish
studi
attribut
brd
preval
incid
found
brd
unit
kingdom
johnson
et
al
brd
control
sever
strategi
correct
use
colostrum
pardon
et
al
vaccin
program
richeson
et
al
widespread
use
antimicrobi
brd
treatment
control
de
briyn
et
al
repres
one
major
use
antimicrobi
food
produc
anim
fulton
nickel
white
brd
multifactori
diseas
associ
host
suscept
environment
condit
manag
presenc
load
pathogen
infect
result
inflamm
damag
respiratori
tract
sever
case
result
death
pathogenesi
attribut
primari
viral
infect
subsequ
bacteri
colon
compromis
epithelium
caus
secondari
infect
angen
et
al
sudaryatma
et
al
viral
interact
immun
system
lead
immun
suppress
impair
host
respons
secondari
bacteri
infect
czuprynski
et
al
field
diagnosi
brd
base
clinic
sign
support
microbiolog
clinic
specimen
tracheal
aspir
fluid
nasal
swab
lung
tissu
sampl
howev
fals
neg
result
commonli
encount
causal
bacteria
may
fastidi
slow
grow
possibl
overgrown
organ
bell
et
al
kugada
et
al
shanthalingam
et
al
tegtmeier
et
al
serolog
assay
elisa
frequent
use
indic
prior
infect
bovi
fals
neg
result
earli
infect
occur
seroconvers
normal
take
two
week
howard
et
al
petersen
et
al
wide
rang
polymeras
chain
reaction
pcr
assay
develop
test
individu
pathogen
involv
brd
amer
et
al
bell
et
al
klem
et
al
kishimoto
et
al
rahpaya
et
al
howev
test
multipl
brd
pathogen
separ
assay
prohibit
expens
livestock
produc
overcom
problem
multiplex
pcr
assay
recent
develop
zhang
et
al
although
individu
bacteri
viral
pathogen
caus
diseas
alon
mix
infect
common
problemat
brd
rapid
diagnosi
pathogen
also
essenti
implement
appropri
treatment
control
measur
convent
pcr
problemat
pathogen
present
healthi
diseas
calv
situat
multiag
diseas
opportunist
pathogen
quantif
pathogen
clinic
specimen
ad
substanti
valu
microbiolog
diagnosi
lima
et
al
pedersen
et
al
pedersen
et
al
recent
multiplex
quantit
pcr
qpcr
method
detect
relev
bacteri
pathogen
brd
publish
demonstr
better
perform
cultur
coinfect
two
pathogen
loy
et
al
offer
quick
complet
laboratori
result
multipl
brd
pathogen
set
two
commerci
avail
multiplex
qpcr
assay
develop
name
dna
diagnost
risskov
denmark
multiplex
qpcr
kit
specif
detect
quantit
four
bacteri
haemolytica
p
multocida
h
somni
bovi
five
viral
bcov
brsv
bvdv
pathogen
respect
frequent
associ
brd
studi
perform
kit
evalu
compar
result
test
field
sampl
bacteri
cultur
pcr
test
bovi
bcov
brsv
routin
use
denmark
refer
standard
method
two
set
tracheal
aspir
ta
sampl
calv
without
sign
pneumonia
use
sampl
collect
danish
calf
farm
respect
two
set
sampl
use
develop
prior
first
set
use
valid
bacteri
assay
want
risk
fals
neg
result
subsequ
viral
test
due
prolong
sampl
storag
viral
test
second
set
sampl
obtain
ethic
approv
studi
requir
sinc
sampl
taken
part
routin
work
perform
herd
veterinarian
ta
sampl
collect
previous
describ
doyl
et
al
author
veterinarian
veterinari
student
supervis
ta
sampl
approx
ml
divid
multipl
aliquot
first
set
sampl
one
aliquot
use
plate
detect
haemolytica
p
multocida
h
somni
cultur
carri
immedi
sampl
second
aliquot
use
detect
pathogen
brd
last
aliquot
store
reserv
sampl
c
second
set
sampl
one
aliquot
without
preserv
use
detect
bcov
brsv
bovi
realtim
rtpcr
danish
nation
veterinari
institut
nvi
lyngbi
denmark
second
use
detect
bovi
third
detect
viral
pathogen
last
aliquot
store
reserv
sampl
c
aliquot
ta
sampl
ml
centrifug
min
g
pellet
suspend
ml
phosphat
buffer
salin
pb
ph
one
ml
sampl
spread
drigalski
spatula
three
blood
agar
plate
oxoid
contain
calf
blood
supplement
amphotericin
b
sigmaaldrich
incub
c
co
incub
h
coloni
display
typic
morpholog
p
multocida
haemolytica
h
somni
subject
malditof
ms
identif
use
vitek
ms
ruo
instrument
marci
letoil
franc
chca
matrix
solut
vitek
sa
accord
manufactur
standard
procedur
spectra
data
analys
sarami
databas
purifi
cultur
suspend
brain
heart
infus
broth
oxoid
contain
glycerol
store
c
allow
reidentif
see
usda
nahm
feedlot
studi
http
wwwaphisusdagov
aphisourfocusanimalhealthmonitoringandsurveillancenahmsnahmsfeedlotstudi
access
januari
see
fagan
j
fee
barret
johnson
allisland
anim
diseas
surveil
report
http
www
afbinigovuksitesafbinigovukfilespublicationsal
access
januari
estim
analyt
sensit
assay
clone
viral
rna
gene
target
sequenc
use
without
reveal
target
gene
sequenc
author
consortium
manufactur
suppli
obtain
plasmid
dna
clone
viral
target
gene
sequenc
commerci
supplier
genscript
biotech
plasmid
transfect
e
coli
life
technolog
europ
bv
purifi
e
coli
use
qiagen
plasmid
mini
kit
qiagen
accord
manufactur
protocol
rna
transcrib
vitro
use
megascript
transcript
kit
life
technolog
europ
bv
accord
manufactur
protocol
residu
dna
remov
turbo
dnase
life
technolog
europ
bv
rna
purifi
use
megaclear
transcript
cleanup
kit
life
technolog
europ
bv
rna
qualiti
integr
measur
nanodrop
spectrophotomet
saveen
werner
ap
rna
dna
ta
sampl
extract
use
extract
kit
dna
diagnost
accord
manufactur
instruct
briefli
rna
dna
extract
ml
sampl
use
prelysi
buffer
c
min
cell
harvest
centrifug
g
wash
wash
buffer
rna
dna
recov
c
min
follow
incub
c
min
ml
lysi
mix
buffer
debri
pellet
centrifug
lysat
supernat
contain
rna
andor
dna
either
use
immedi
store
c
bacteri
qpcr
detect
c
viral
rtqpcr
detect
kit
consist
two
set
qpcr
assay
kit
dna
diagnost
contain
primer
taqman
probe
design
detect
dna
haemolytica
p
multocida
h
somni
bovi
primer
sequenc
releas
compani
qpcr
perform
use
p
qpcr
system
follow
cycl
paramet
c
min
follow
cycl
c
c
machin
set
acquir
fluoresc
rox
hex
fam
atto
channel
haemolytica
p
multocida
h
somni
bovi
amplicon
intern
amplif
control
iac
respect
kit
dna
diagnost
contain
primer
taqman
probe
detect
sequenc
bcov
brsv
bvdv
viral
rna
extract
sampl
test
use
twostep
rtqpcr
method
first
rt
reaction
cdna
synthesi
incub
c
min
incub
c
min
second
step
qpcr
stage
perform
cycl
paramet
assay
machin
set
acquir
fluoresc
rox
hex
fam
atto
channel
bcov
brsv
intern
amplif
control
iac
respect
test
result
analyz
use
mxpro
qpcr
softwar
sampl
cycl
threshold
ct
cycl
less
consid
posit
evalu
perform
viral
pathogen
detect
respect
bovi
detect
comparison
standard
singleplex
qpcr
method
use
nvi
denmark
undertaken
effici
sensit
kit
evalu
amplif
serial
dilut
copi
number
bacteri
viral
nucleic
acid
four
bacteri
target
genom
dna
use
five
viral
target
rna
gener
plasmid
contain
target
gene
sequenc
viru
use
dilut
target
nucleic
acid
perform
pb
dilut
run
triplic
mean
ct
valu
plot
log
nucleic
acid
copi
number
target
pcr
effici
e
target
percentag
calcul
base
slope
curv
use
formula
e
svec
et
al
quantifi
bacteri
load
ct
valu
qpcr
test
compar
bacteri
coloni
form
unit
cfu
target
bacteria
four
bacteria
three
differ
isol
test
serial
dilut
nacl
made
overnight
cultur
serum
bouillon
broth
ssi
diagnostica
dna
extract
ml
dilut
test
pcr
simultan
number
bacteri
cell
enumer
plate
dilut
onto
blood
agar
plate
eurofin
stein
laboratorium
haemolytica
p
multocida
h
somni
mycoplasma
agar
plate
oxoid
contain
supplement
g
oxoid
bovi
blood
agar
plate
incub
c
co
h
mycoplasma
agar
plate
incub
day
cfu
target
bacteria
calcul
plate
contain
coloni
bacteri
load
log
ml
plot
correspond
ct
valu
assay
specif
evalu
pure
cultur
haemolytica
n
p
multocida
n
h
somni
n
bovi
n
strain
nontarget
bacteria
refer
supplementari
tabl
strain
detail
diagnost
sensit
specif
kit
evalu
test
nucleic
acid
target
extract
clinic
sampl
first
set
ta
examin
compar
result
bacteri
cultur
refer
standard
method
detect
haemolytica
p
multocida
h
somni
second
set
ta
sampl
analyz
v
viral
pathogen
bovi
compar
result
standard
qpcr
viral
pathogen
bovi
describ
diagnost
sensit
specif
confid
interv
calcul
use
dag
stat
spreadsheet
mackinnon
cohen
kappa
coeffici
use
describ
agreement
result
bacteri
cultur
pcr
virus
bovi
kappa
valu
interpret
slight
agreement
fair
agreement
moder
agreement
substanti
agreement
almost
perfect
agreement
landi
koch
base
serial
dilut
genom
dna
plasmid
rna
limit
detect
ct
copi
nucleic
acid
per
reaction
depend
assay
coeffici
determin
r
ct
valu
copi
nucleic
acid
per
assay
assay
qpcr
effici
e
rang
fig
v
fig
quantif
bacteri
target
rang
log
ml
haemolytica
log
ml
p
multocida
log
ml
h
somni
log
ml
bovi
fig
kit
detect
strain
haemolytica
p
multocida
h
somni
bovi
test
posit
reaction
observ
nontarget
bovin
bacteria
first
set
ta
sampl
n
test
use
bacteri
cultur
result
ct
valu
per
sampl
appear
supplementari
tabl
ct
valu
posit
sampl
rang
haemolytica
p
multocida
h
somni
use
standard
curv
fig
correspond
bacteri
load
log
valu
posit
sampl
three
pathogen
respect
result
comparison
pcr
bacteri
cultur
haemolytica
p
multocida
h
somni
base
ta
sampl
shown
tabl
bacteri
cultur
refer
standard
correspond
diagnost
sensit
specif
pcr
haemolytica
p
multocida
h
somni
tabl
agreement
pcr
bacteri
cultur
moder
high
bacteri
target
kappa
valu
haemolytica
p
multocida
h
somni
respect
sampl
comparison
bovi
detect
pcr
nvi
qpcr
refer
standard
tabl
test
diagnost
sensit
diagnost
specif
moder
agreement
kappa
two
test
result
viral
target
pcr
compar
three
virus
qpcr
nvi
refer
standard
also
shown
tabl
detail
result
includ
ct
valu
appear
supplementari
tabl
high
diagnost
sensit
diagnost
specif
bcov
brsv
respect
found
tabl
agreement
refer
method
also
high
viral
target
kappa
bcov
brsv
respect
expect
ta
sampl
danish
calv
test
neg
bvdv
assay
develop
provid
rapid
effect
detect
pathogen
involv
brd
total
nine
pathogen
multiplex
qpcr
assay
run
time
pcr
program
benefit
cost
process
time
diagnost
laboratori
compar
multipl
singleplex
qpcr
assay
run
parallel
howev
effici
sensit
multiplex
pcr
compromis
due
primer
probe
set
interf
competit
compon
reaction
kall
et
al
parker
et
al
studi
commerciallyavail
multiplex
qpcr
assay
demonstr
effici
seven
target
pathogen
respect
compar
publish
singleplex
qpcr
assay
kishimoto
et
al
abl
detect
copi
genom
dna
copi
target
rna
per
reaction
respect
compar
previous
establish
method
report
copi
per
reaction
rahpaya
et
al
qpcr
effici
also
similar
multiplex
qpcr
assay
report
other
wisselink
et
al
assay
demonstr
number
ta
sampl
n
pcr
posit
haemolytica
p
multocida
h
somni
neg
cultur
method
tabl
result
suggest
bacteria
present
undetect
cultur
possibl
due
fastidi
natur
overgrowth
organ
cultur
bell
et
al
van
driessch
et
al
pcr
method
like
overcom
effect
accompani
flora
detect
pathogen
mix
sampl
tradit
cultur
fail
loy
et
al
limit
cultur
refer
standard
assay
must
consid
determin
diagnost
specif
sensit
correctli
identifi
bacteri
speci
undetect
cultur
specif
assay
would
underestim
similar
number
sampl
n
posit
haemolytica
p
multocida
h
somni
cultur
neg
assay
tabl
confirm
qpcr
result
fals
neg
result
previous
report
bell
et
al
explan
could
primer
probe
mismatch
degrad
nucleic
acid
storag
handl
technic
error
extract
present
studi
major
cultur
positivepcr
neg
sampl
contain
low
number
bacteri
cell
supplementari
tabl
possibl
result
low
amount
sampl
use
dna
extract
compar
larger
volum
use
cultur
howev
target
bacteria
could
sequenc
substitut
primer
probe
recognit
site
sinc
primer
sequenc
releas
compani
mean
investig
accord
compani
primer
design
includ
comparison
avail
genom
sequenc
target
bacteria
observ
problem
bacteri
cultur
use
kit
test
pcr
inhibitor
may
also
caus
result
found
sampl
cultur
positivepcr
neg
result
unaccept
low
pcr
signal
intern
amplif
control
iac
signal
ct
becam
pcr
posit
retest
fold
dilut
dna
extract
howev
method
comparison
classifi
sampl
pcr
neg
bovi
qpcr
test
identifi
posit
ta
sampl
refer
method
tabl
rule
may
cross
react
speci
mycoplasma
test
current
studi
howev
sampl
posit
method
gave
result
ct
valu
lower
result
standard
pcr
supplementari
tabl
suggest
assay
higher
sensit
bovi
refer
method
sever
factor
influenc
pcr
effici
sampl
storag
transport
differ
materi
buzard
et
al
reagent
includ
dna
prepar
method
bowman
et
al
dilhari
et
al
may
explain
sensit
differ
two
method
bovi
detect
moder
agreement
two
assay
also
consist
assay
sensit
refer
standard
refer
variou
techniqu
includ
cell
cultur
serolog
fluoresc
antibodi
test
elisa
nucleic
acid
test
use
laboratori
diagnosi
viral
infect
brd
albayrak
et
al
timsit
et
al
differ
sensit
specif
none
optim
refer
standard
abl
detect
virus
clinic
situat
studi
use
offici
danish
qpcr
viral
detect
protocol
nation
veterinari
laboratori
accredit
refer
standard
refer
singleplex
assay
comparison
standard
method
multiplex
assay
equal
slightli
sensit
sampl
n
posit
bcov
brsv
pcr
neg
standard
pcr
wherea
one
posit
standard
pcr
neg
ct
valu
posit
sampl
supplementari
tabl
rule
high
ct
may
gener
crosscontamin
nonspecif
amplif
viral
speci
test
studi
nucleic
acid
extract
protocol
includ
assay
includ
high
speed
centrifug
initi
step
howev
also
case
nvi
protocol
unlik
extract
protocol
harvest
free
viru
particl
requir
centrifug
speed
g
payn
howev
sinc
sick
calv
high
number
virusinfect
neutrophil
macrophag
lymphocyt
lung
et
al
enough
target
particl
like
obtain
diagnost
sensit
specif
valid
sampl
danish
farm
limit
sinc
denmark
free
bvdv
thu
diagnost
sensit
bvdv
could
evalu
result
ta
sampl
inde
neg
bvdv
v
standard
pcr
indic
assay
two
virus
v
crossreact
bovin
respiratori
virus
denmark
routin
use
free
countri
import
bvdv
assay
high
specif
falseposit
detect
regulatori
trade
implic
addit
studi
evalu
sensit
v
clinic
sampl
contain
bvdv
need
fast
specif
sensit
multiplex
qpcr
assay
detect
haemolytica
p
multocida
h
somni
bovi
bcov
brsv
v
confirm
kit
tracheal
aspir
specimen
danish
calv
offer
altern
standard
method
routin
diagnost
j
katholm
p
pansri
employe
dna
diagnost
produc
sell
kit
none
author
financi
person
relationship
could
inappropri
influenc
bia
content
paper
